Study With T-cel Receptor Gene Therapy in Metastatic Melanoma
Clinical trial NCT02654821 · UNKNOWN
Trial details
- NCT number
- NCT02654821
- Sponsor
- The Netherlands Cancer Institute
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-03-01
- Primary completion
- 2019-10-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.